Peijia Medical Limited Total Assets
Peijia Medical Limited total assets. Based on the latest financial reports, Peijia Medical Limited (4WO) holds total assets worth €2.66 Billion EUR (≈ $3.11 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Peijia Medical Limited for the company's overall valuation and market capitalisation.
Total Assets of Peijia Medical Limited (2018–2025)
Total assets of Peijia Medical Limited from 2018 to 2025. This chart illustrates how Peijia Medical Limited's total assets have evolved over time, based on quarterly financial data. See today's stock price for Peijia Medical Limited for real-time trading data and today's change.
Peijia Medical Limited - Asset Composition Analysis
Peijia Medical Limited Total Assets Breakdown (December 2025)
Peijia Medical Limited total assets breakdown as of December 2025. Peijia Medical Limited's total assets of €2.66 Billion consist of 30.9% current assets and 69.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 20.2% |
| Accounts Receivable | €46.19 Million | 1.7% |
| Inventory | €145.91 Million | 5.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €718.73 Million | 27.1% |
| Goodwill | €51.66 Million | 1.9% |
Asset Composition Trend (2018–2025)
This chart illustrates how Peijia Medical Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Peijia Medical Limited (4WO) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Peijia Medical Limited's current assets represent 30.9% of total assets in 2025, a decrease from 80.9% in 2018.
- Cash Position: Cash and equivalents constituted 20.2% of total assets in 2025, down from 54.4% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 27.1% of total assets.
Peijia Medical Limited Competitors by Total Assets
Key competitors of Peijia Medical Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Peijia Medical Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.21 | 2.23 | 57.31 |
| Quick Ratio | 1.00 | 1.91 | 56.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €143.06 Million | €544.30 Million | €2.50 Billion |
Peijia Medical Limited - Advanced Valuation Insights
This section examines the relationship between Peijia Medical Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.75 |
| Latest Market Cap to Assets Ratio | 0.11 |
| Asset Growth Rate (YoY) | -1.2% |
| Total Assets | €2.66 Billion |
| Market Capitalization | $299.00 Million USD |
Valuation Analysis
Below Book Valuation: The market values Peijia Medical Limited's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Peijia Medical Limited's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Peijia Medical Limited (2018–2025)
The table below shows the annual total assets of Peijia Medical Limited from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €2.66 Billion ≈ $3.11 Billion |
-1.19% |
| 2024-12-31 | €2.69 Billion ≈ $3.14 Billion |
+0.63% |
| 2023-12-31 | €2.67 Billion ≈ $3.12 Billion |
-19.43% |
| 2022-12-31 | €3.32 Billion ≈ $3.88 Billion |
+4.83% |
| 2021-12-31 | €3.16 Billion ≈ $3.70 Billion |
+9.80% |
| 2020-12-31 | €2.88 Billion ≈ $3.37 Billion |
+227.61% |
| 2019-12-31 | €879.48 Million ≈ $1.03 Billion |
+404.40% |
| 2018-12-31 | €174.36 Million ≈ $203.85 Million |
-- |
About Peijia Medical Limited
Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People's Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company's products inc… Read more